drugset / Trial / NCT03837379

Goal2Quit + NRT Sampling

NCT03837379

RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this work is to develop, systematically evaluate, and clinically test an integrated cessation intervention comprised of a depression-specific Behavioral Activation (BA) for cessation mobile app ("Goal2Quit") packaged with nicotine replacement therapy (NRT) sampling. This integrated intervention will address the need for an easily disseminable, evidence-based, depression-specific cessation intervention for delivery via primary care.

Timeline

Start
2020-06-22
Primary completion
2022-05-18
Completion
2022-05-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 4 mg Topical
Subject Nicotine Unknown 14 mg Topical

Indications